Journal
ANTIVIRAL RESEARCH
Volume 122, Issue -, Pages 91-100Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2015.08.005
Keywords
Hepatitis B virus; cccDNA; DNA repair; Innate immunity; Antiviral
Categories
Funding
- NIH Grant [R01AI113267, R01AI094474, R21AI103838]
- Hepatitis B Foundation through Commonwealth of Pennsylvania
- Trustees of Indiana University
Ask authors/readers for more resources
Persistent hepatitis B virus (HBV) infection relies on the stable maintenance and proper functioning of a nuclear episomal form of the viral genome called covalently closed circular (ccc) DNA. One of the major reasons for the failure of currently available antiviral therapeutics to achieve a cure of chronic HBV infection is their inability to eradicate or inactivate cccDNA. In this review article, we summarize our current understanding of cccDNA metabolism in hepatocytes and the modulation of cccDNA by host pathophysiological and immunological cues. Perspectives on the future investigation of cccDNA biology, as well as strategies and progress in therapeutic elimination and/or transcriptional silencing of cccDNA through rational design and phenotypic screenings, are also discussed. This article forms part of a symposium in Antiviral Research on An unfinished story: from the discovery of the Australia antigen to the development of new curative therapies for hepatitis B. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available